Nathan D Camp
Overview
Explore the profile of Nathan D Camp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
710
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hill T, Narvekar P, Asher G, Edelstein J, Camp N, Grimm A, et al.
Mol Ther
. 2024 Jul;
32(8):2676-2691.
PMID: 38959896
Bispecific antibodies are an important tool for the management and treatment of acute leukemias. As a next step toward clinical translation of engineered plasma cells, we describe approaches for secretion...
2.
Cheng R, Hung K, Zhang T, Stoffers C, Ott A, Suchland E, et al.
Nat Commun
. 2022 Oct;
13(1):6110.
PMID: 36245034
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells have the potential to be used as a cell therapy for protein replacement. Here,...
3.
Thomas K, Allenspach E, Camp N, Wray-Dutra M, Khim S, Zielinska-Kwiatkowska A, et al.
Leukemia
. 2021 Jul;
36(1):42-57.
PMID: 34193976
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk subtype of B-ALL often associated with genetic variants that alter cytokine receptor signaling, including mutations in the interleukin-7 receptor (IL7R)....
4.
Tsui J, Leonard A, Camp N, Long J, Nawas Z, Chavanachat R, et al.
Biomaterials
. 2021 Apr;
272:120764.
PMID: 33798964
Cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSCs) offer tremendous potential when used to engineer human tissues for drug screening and disease modeling; however, phenotypic immaturity reduces assay reliability...
5.
Meitlis I, Allenspach E, Bauman B, Phan I, Dabbah G, Schmitt E, et al.
Am J Hum Genet
. 2020 Nov;
107(6):1029-1043.
PMID: 33202260
Genetic testing has increased the number of variants identified in disease genes, but the diagnostic utility is limited by lack of understanding variant function. CARD11 encodes an adaptor protein that...
6.
Mikheeva S, Camp N, Huang L, Jain A, Jung S, Avci N, et al.
Cancers (Basel)
. 2019 Sep;
11(9).
PMID: 31540485
Diffuse invasion into adjacent brain matter by glioblastoma (GBM) is largely responsible for their dismal prognosis. Previously, we showed that the TWIST1 (TW) bHLH transcription factor and its regulated gene...
7.
Koksal A, Beck K, Cronin D, McKenna A, Camp N, Srivastava S, et al.
Cell Rep
. 2018 Sep;
24(13):3607-3618.
PMID: 30257219
We present a method for automatically discovering signaling pathways from time-resolved phosphoproteomic data. The Temporal Pathway Synthesizer (TPS) algorithm uses constraint-solving techniques first developed in the context of formal verification...
8.
Sychev Z, Hu A, DiMaio T, Gitter A, Camp N, Noble W, et al.
PLoS Pathog
. 2017 Mar;
13(3):e1006256.
PMID: 28257516
Kaposi's Sarcoma associated Herpesvirus (KSHV), an oncogenic, human gamma-herpesvirus, is the etiological agent of Kaposi's Sarcoma the most common tumor of AIDS patients world-wide. KSHV is predominantly latent in the...
9.
Rose J, Huang P, Camp N, Ye J, Leidal A, Goreshnik I, et al.
Nat Chem Biol
. 2016 Nov;
13(1):119-126.
PMID: 27870838
Synthetic protein switches controlled with user-defined inputs are powerful tools for studying and controlling dynamic cellular processes. To date, these approaches have relied primarily on intermolecular regulation. Here we report...
10.
Kountz T, Lee K, Aggarwal-Howarth S, Curran E, Park J, Harris D, et al.
J Biol Chem
. 2016 Jul;
291(35):18210-21.
PMID: 27382054
The α1D-adrenergic receptor (ADRA1D) is a key regulator of cardiovascular, prostate, and central nervous system functions. This clinically relevant G protein-coupled receptor has proven difficult to study, as it must...